Teva Pharmaceutical Industries Ltd. — Earnings Release 2009

Nov 3, 2009

_________ false

C002��� ������ ��������� ��"�2PublicTEVA- PHARMACEUTICAL INDUSTRIES LTD.7217Corporation no: 520013954Stock Exchange/Market: ���310380P.O.B 3190 , Petach Tikva 49131 , ,Tel: 03-9267554 , 03-9267652 Fax: 03-9267519E.mail address: elana.holzman@teva.co.ilDate of transmission: 03/11/2009              Time of broadcast: 08:32 08:22:16

Reference: 2009-02-272451

Israel Securities Authority		Tel Aviv Stock Exchange
www.isa.gov.il		www.tase.co.il

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on TEVA REPORTS THIRD QUARTER 2009 RESULTS
Q309_earnings_final031109_isa.pdf

Please find attached a press release issued in the US on November 3, 2009, and its non binding Hebrew translation, provided for convenience purposes only.
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity:
Date of revision of form structure: 18/10/2009
- - -
Name of the Signatory: : Desheh Eyal , Position of Signatory in the reporting corporation: Chief Financial Officer , Name of Employer Company: .
Basel Telephone: 02-9411717 , Facsimile: 02-9411718 , E-mail: eyal@teva.co.il 2